Related Experiment Video
Updated: May 12, 2026
06:35
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Mutant Cu,Zn superoxide dismutase in motor neuron disease
Age
|April 23, 2013
Summary
Mutations in the SOD1 gene cause familial ALS by converting the protective Cu,Zn superoxide dismutase (Cu,Zn SOD) enzyme into a toxic form. This altered enzyme generates harmful oxygen radicals, leading to motor neuron death and disease progression.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Cu,Zn superoxide dismutase (Cu,Zn SOD) is a key antioxidant enzyme protecting cells from oxygen free radical damage.
- Mutations in the SOD1 gene are linked to familial amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease.
- Motor neuron degeneration is the hallmark of ALS, leading to progressive paralysis.
Purpose of the Study:
- To investigate the mechanism by which SOD1 mutations contribute to familial ALS.
- To understand how mutant Cu,Zn SOD gains toxic properties.
- To explore the role of oxidative stress in ALS pathogenesis.
Main Methods:
- Analysis of SOD1 gene mutations.
- In vitro studies of mutant Cu,Zn SOD enzyme activity.
- In vivo studies using transgenic mouse models expressing mutant human Cu,Zn SOD.
Main Results:
- Mutant Cu,Zn SOD exhibits enhanced generation of oxygen radicals compared to the wild-type enzyme.
- Expression of mutant human Cu,Zn SOD in transgenic mice reproduces ALS-like pathology.
- The mutation converts the antioxidant enzyme into a pro-oxidant form.
Conclusions:
- SOD1 mutations transform a protective enzyme into a destructive one, promoting free radical damage.
- This pro-oxidant activity of mutant Cu,Zn SOD is toxic to motor neurons, explaining their selective vulnerability in ALS.
- Targeting the pro-oxidant activity of mutant SOD1 may offer therapeutic strategies for familial ALS.
